1.Effect Mechanism and Law of Sterilization by 60Co-γ Ray Irradiation on Chemical Composition of Chinese Materia Medica: A Review
Tingting ZHU ; Jian RANG ; Rangyanpo LUO ; Rui GU ; Yue YANG ; Si LU ; Shihong ZHONG
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(18):306-314
		                        		
		                        			
		                        			60Co-γ ray irradiation has the unique advantages of high efficiency, strong penetration, operation at room temperature and no residue, which has been widely used in the sterilization of Chinese medicinal materials, decoction pieces, Chinese patent medicine. However, the irradiation effect may cause changes in the content of chemical components in Chinese materia medica or the emergence of new radiolysis products, leading to reduced efficacy and uncontrollable safety risks. This paper reviewed the relevant literature at home and abroad, summarized the effect of irradiation sterilization on various types of chemical compositions of Chinese medicinal materials and their preparations, and analyzed and explored the rule of change. The results showed that the content changes of various chemical components in Chinese materia medica after 60Co-γ ray irradiation sterilization varied. The contents of most flavonoids, terpenoids, phenylpropanoids and quinones decreased after irradiation, and the degree of decrease increased with the elevated irradiation dose. The contents of lignans, alkaloids, isoflavones and some terpenoids did not change significantly before and after irradiation, while the content changes of triterpenoid saponins, dihydroflavonols, chalcones, sugars and glycosides after irradiation were not yet uniform. Therefore, it is recommended to pay attention to the compositional changes of irradiated Chinese medicines, strengthen the research on the standards of irradiated Chinese medicines, and standardize the irradiation and sterilization of Chinese medicines in order to promote the healthy and rational application of irradiated Chinese medicines. 
		                        		
		                        		
		                        		
		                        	
2.Research progress on main disease-related factors of healthy life expectancy.
Heng Shuo LIU ; Zhu WU ; Rui Yue YANG ; Guan Zhou CHEN ; Ying LI ; Si Cheng DU ; Qi ZHOU ; Hui Ping YUAN ; Ze YANG ; Liang SUN
Chinese Journal of Preventive Medicine 2023;57(5):654-658
		                        		
		                        			
		                        			International research on healthy life expectancy (HALE) focuses on inequality of socioeconomic status and individual natural attributes. With the acceleration of population ageing and the increase in average life expectancy, the extension of unhealthy life expectancy and the increase of social and economic burden caused by diseases have gradually attracted the attention of countries around the world. Therefore, the evaluation of disease factors affecting HALE is a meaningful direction in the future. This study introduces the development process and commonly used measurement methods of HALE. According to the definition of health from the Global Burden of Disease Study and World Health Organization, physical and mental diseases such as cardiovascular and cerebrovascular diseases, chronic respiratory diseases, diabetes, malignant tumors and depression were selected to summarize the impact of these diseases and pre-disease states on HALE. It is expected to provide a theoretical basis for the formulation of relevant public health policies and the improvement of quality of life in China.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Healthy Life Expectancy
		                        			;
		                        		
		                        			Quality of Life
		                        			;
		                        		
		                        			Life Expectancy
		                        			;
		                        		
		                        			Causality
		                        			;
		                        		
		                        			Social Class
		                        			
		                        		
		                        	
3.Progress in research of risk prediction of non-syndromic oral clefts using genetic information.
Si Yue WANG ; He Xiang PENG ; En Ci XUE ; Xi CHEN ; Xue Heng WANG ; Meng FAN ; Meng Ying WANG ; Nan LI ; Jing LI ; Zhi Bo ZHOU ; Hong Ping ZHU ; Yong Hua HU ; Tong WU
Chinese Journal of Epidemiology 2023;44(3):504-510
		                        		
		                        			
		                        			Non-syndromic oral cleft (NSOC), a common birth defect, remains to be a critical public health problem in China. In the context of adjustment of childbearing policy for two times in China and the increase of pregnancy at older childbearing age, NSOC risk prediction will provide evidence for high-risk population identification and prenatal counseling. Genome-wide association study and second generation sequencing have identified multiple loci associated with NSOC, facilitating the development of genetic risk prediction of NSOC. Despite the marked progress, risk prediction models of NSOC still faces multiple challenges. This paper summarizes the recent progress in research of NSOC risk prediction models based on the results of extensive literature retrieval to provide some insights for the model development regarding research design, variable selection, model-build strategy and evaluation methods.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Cleft Palate/genetics*
		                        			;
		                        		
		                        			Cleft Lip/genetics*
		                        			;
		                        		
		                        			Genome-Wide Association Study
		                        			;
		                        		
		                        			Genetic Predisposition to Disease
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Polymorphism, Single Nucleotide
		                        			
		                        		
		                        	
4.Design and implementation of integrated simulation training system of tactical combat casualty care for mobile medical detachments
Si-Yue ZHU ; Ying SUN ; Ling-Hui KONG ; Qin-Ge YONG ; Yuan GAO
Chinese Medical Equipment Journal 2023;44(12):14-19
		                        		
		                        			
		                        			Objective To design an integrated simulation training system of tactical combat casualty care for mobile medical detachments to realize training of mass casualty treatment at wartime.Methods An integrated simulation training system of tactical combat casualty care for mobile medical detachments was developed with UE4 unreal engine and Vue.js framework for developing visual interface scenes,3D modeling for building war simulation scenarios,Java programming language for writing backend logic code and MySQL database for data recording.There were four functional modules involved in the system developed for micro class,self-assessment,game simulation and record query.Results The system developed realized integrated training for attending class,practice,test and review,and enhanced the efficacy for training of tactical combat casualty care.Conclusions The system developed contributes to increasing the combat casualty care capability of mobile medical detachments.
		                        		
		                        		
		                        		
		                        	
5.Evaluation of the predictive effect of PD-L1 expression on survival in early triple-negative breast cancer.
Jian YUE ; Xue WANG ; An Jie ZHU ; Ding Yuan WANG ; Song Lin GAO ; Nan Lin HU ; Yi Ran SI ; Fang Chao ZHENG ; Jie JU ; Zheng WANG ; Peng YUAN
Chinese Journal of Oncology 2023;45(11):948-954
		                        		
		                        			
		                        			Objectives: To find the prognostic factors related to early triple-negative breast cancer to optimize the therapeutic strategies, and explore the influence of programmed cell death ligand-1(PD-L1)expression in early triple-negative breast cancer on its prognosis, so as to provide support for clinical treatment decisions. Methods: Early triple-negative breast cancer patients treated at the National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences during 1st June, 2009 and 31st Oct, 2015 were enrolled in this study. All the clinicopathological data of patients were collected, and the paraffin sections of the surgical specimens were stained with estrogen receptor, progesterone receptor, human epidermal growth factor receptor-2, secreted protein acidic and rich in cysteine (SPARC), androgen receptor, PD-L1 and other antibodies by the immunohistochemical method. Kaplan-Meier survival and Cox regression curves were used for survival analysis of relevant clinical and pathological results and nomogram survival prediction models were established to explore the influence of relevant factors on the prognosis. Results: A total of 205 patients with triple-negative breast cancer were enrolled. Ninety patients (43.9%) were PD-L1 positive. The median follow-up time was 63 months. Thirty-seven patients were relapsed or recurrent and 16 patients were dead. The 5-year disease-free survival (DFS) rate and overall survival (OS) rate were 86.1% (95% CI: 81.4%-90.8%) and 93.6% (95% CI: 91.0%-97.6%), respectively, in the general population. Univariate Cox regression analysis showed that PD-L1 expression and lymph node metastasis were correlated with DFS and OS (P<0.05). In multivariate analysis, PD-L1 expression was an independent influencing factor of DFS, with PD-L1 positive patients possessing a significant survival benefit in DFS (HR=0.31, 95% CI: 0.13-0.73). Lymph node metastasis was an independent influencing factor of OS, and OS was significantly shortened in patients with positive lymph node metastasis (HR=3.24, 95% CI: 1.15-9.17). PD-L1, lymph node metastasis, menopausal status, Ki-67 index and adjuvant chemotherapy regimen were included to establish the 1- and 3-year DFS and OS nomogram prediction models, resulting in C indices of 0.698 and 0.748, respectively. Conclusions: PD-L1 expression is a predictive biomarker of good prognostic factor in triple-negative breast cancer patients. DFS is significantly prolonged in PD-L1 positive patients and OS also shows a prolongation trend. The nomogram prognosis prediction models have reference values for adjuvant chemotherapy in this patient group.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Lymphatic Metastasis
		                        			;
		                        		
		                        			B7-H1 Antigen/metabolism*
		                        			;
		                        		
		                        			Triple Negative Breast Neoplasms/pathology*
		                        			;
		                        		
		                        			Breast Neoplasms
		                        			;
		                        		
		                        			Osteonectin/therapeutic use*
		                        			;
		                        		
		                        			Prognosis
		                        			
		                        		
		                        	
6.Evaluation of the predictive effect of PD-L1 expression on survival in early triple-negative breast cancer.
Jian YUE ; Xue WANG ; An Jie ZHU ; Ding Yuan WANG ; Song Lin GAO ; Nan Lin HU ; Yi Ran SI ; Fang Chao ZHENG ; Jie JU ; Zheng WANG ; Peng YUAN
Chinese Journal of Oncology 2023;45(11):948-954
		                        		
		                        			
		                        			Objectives: To find the prognostic factors related to early triple-negative breast cancer to optimize the therapeutic strategies, and explore the influence of programmed cell death ligand-1(PD-L1)expression in early triple-negative breast cancer on its prognosis, so as to provide support for clinical treatment decisions. Methods: Early triple-negative breast cancer patients treated at the National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences during 1st June, 2009 and 31st Oct, 2015 were enrolled in this study. All the clinicopathological data of patients were collected, and the paraffin sections of the surgical specimens were stained with estrogen receptor, progesterone receptor, human epidermal growth factor receptor-2, secreted protein acidic and rich in cysteine (SPARC), androgen receptor, PD-L1 and other antibodies by the immunohistochemical method. Kaplan-Meier survival and Cox regression curves were used for survival analysis of relevant clinical and pathological results and nomogram survival prediction models were established to explore the influence of relevant factors on the prognosis. Results: A total of 205 patients with triple-negative breast cancer were enrolled. Ninety patients (43.9%) were PD-L1 positive. The median follow-up time was 63 months. Thirty-seven patients were relapsed or recurrent and 16 patients were dead. The 5-year disease-free survival (DFS) rate and overall survival (OS) rate were 86.1% (95% CI: 81.4%-90.8%) and 93.6% (95% CI: 91.0%-97.6%), respectively, in the general population. Univariate Cox regression analysis showed that PD-L1 expression and lymph node metastasis were correlated with DFS and OS (P<0.05). In multivariate analysis, PD-L1 expression was an independent influencing factor of DFS, with PD-L1 positive patients possessing a significant survival benefit in DFS (HR=0.31, 95% CI: 0.13-0.73). Lymph node metastasis was an independent influencing factor of OS, and OS was significantly shortened in patients with positive lymph node metastasis (HR=3.24, 95% CI: 1.15-9.17). PD-L1, lymph node metastasis, menopausal status, Ki-67 index and adjuvant chemotherapy regimen were included to establish the 1- and 3-year DFS and OS nomogram prediction models, resulting in C indices of 0.698 and 0.748, respectively. Conclusions: PD-L1 expression is a predictive biomarker of good prognostic factor in triple-negative breast cancer patients. DFS is significantly prolonged in PD-L1 positive patients and OS also shows a prolongation trend. The nomogram prognosis prediction models have reference values for adjuvant chemotherapy in this patient group.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Lymphatic Metastasis
		                        			;
		                        		
		                        			B7-H1 Antigen/metabolism*
		                        			;
		                        		
		                        			Triple Negative Breast Neoplasms/pathology*
		                        			;
		                        		
		                        			Breast Neoplasms
		                        			;
		                        		
		                        			Osteonectin/therapeutic use*
		                        			;
		                        		
		                        			Prognosis
		                        			
		                        		
		                        	
7.Family-based association tests for rare variants.
Xi CHEN ; Si Yue WANG ; En Ci XUE ; Xue Heng WANG ; He Xiang PENG ; Meng FAN ; Meng Ying WANG ; Yi Qun WU ; Xue Ying QIN ; Jin LI ; Tao WU ; Hong Ping ZHU ; Jing LI ; Zhi Bo ZHOU ; Da Fang CHEN ; Yonghua HU
Chinese Journal of Epidemiology 2022;43(9):1497-1502
		                        		
		                        			
		                        			Next-generation sequencing has revolutionized family-based association tests for rare variants. As the lower power of genome wide association study for detecting casual rare variants, methods aggregating effects of multiple variants have been proposed, such as burden tests and variance component tests. This paper summarizes the methods of rare variants association test that can be applied for family data, introduces their principles, characteristics and applicable conditions and discusses the shortcomings and the improvement of the present methods.
		                        		
		                        		
		                        		
		                        			Computer Simulation
		                        			;
		                        		
		                        			Family Relations
		                        			;
		                        		
		                        			Genetic Association Studies
		                        			;
		                        		
		                        			Genetic Variation
		                        			;
		                        		
		                        			Genome-Wide Association Study/methods*
		                        			;
		                        		
		                        			Humans
		                        			
		                        		
		                        	
8.Exploring the association between de novo mutations and non-syndromic cleft lip with or without palate based on whole exome sequencing of case-parent trios.
Xi CHEN ; Si Yue WANG ; En Ci XUE ; Xue Heng WANG ; He Xiang PENG ; Meng FAN ; Meng Ying WANG ; Yi Qun WU ; Xue Ying QIN ; Jing LI ; Tao WU ; Hong Ping ZHU ; Jing LI ; Zhi Bo ZHOU ; Da Fang CHEN ; Yong Hua HU
Journal of Peking University(Health Sciences) 2022;54(3):387-393
		                        		
		                        			OBJECTIVE:
		                        			To explore the association between de novo mutations (DNM) and non-syndromic cleft lip with or without palate (NSCL/P) using case-parent trio design.
		                        		
		                        			METHODS:
		                        			Whole-exome sequencing was conducted for twenty-two NSCL/P trios and Genome Analysis ToolKit (GATK) was used to identify DNM by comparing the alleles of the cases and their parents. Information of predictable functions was annotated to the locus with SnpEff. Enrichment analysis for DNM was conducted to test the difference between the actual number and the expected number of DNM, and to explore whether there were genes with more DNM than expected. NSCL/P-related genes indicated by previous studies with solid evidence were selected by literature reviewing. Protein-protein interactions analysis was conducted among the genes with protein-altering DNM and NSCL/P-related genes. R package "denovolyzeR" was used for the enrichment analysis (Bonferroni correction: P=0.05/n, n is the number of genes in the whole genome range). Protein-protein interactions among genes with DNM and genes with solid evidence on the risk factors of NSCL/P were predicted depending on the information provided by STRING database.
		                        		
		                        			RESULTS:
		                        			A total of 339 908 SNPs were qualified for the subsequent analysis after quality control. The number of high confident DNM identified by GATK was 345. Among those DNM, forty-four DNM were missense mutations, one DNM was nonsense mutation, two DNM were splicing site mutations, twenty DNM were synonymous mutations and others were located in intron or intergenic regions. The results of enrichment analysis showed that the number of protein-altering DNM on the exome regions was larger than expected (P < 0.05), and five genes (KRTCAP2, HMCN2, ANKRD36C, ADGRL2 and DIPK2A) had more DNM than expected (P < 0.05/(2×19 618)). Protein-protein interaction analysis was conducted among forty-six genes with protein-altering DNM and thirteen genes associated with NSCL/P selected by literature reviewing. Six pairs of interactions occurred between the genes with DNM and known NSCL/P-related genes. The score measuring the confidence level of the predicted interaction between RGPD4 and SUMO1 was 0.868, which was higher than the scores for other pairs of genes.
		                        		
		                        			CONCLUSION
		                        			Our study provided novel insights into the development of NSCL/P and demonstrated that functional analyses of genes carrying DNM were warranted to understand the genetic architecture of complex diseases.
		                        		
		                        		
		                        		
		                        			Asians
		                        			;
		                        		
		                        			Case-Control Studies
		                        			;
		                        		
		                        			Cleft Lip/genetics*
		                        			;
		                        		
		                        			Cleft Palate/genetics*
		                        			;
		                        		
		                        			Genetic Predisposition to Disease
		                        			;
		                        		
		                        			Genome-Wide Association Study
		                        			;
		                        		
		                        			Genotype
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Mutation
		                        			;
		                        		
		                        			Parents
		                        			;
		                        		
		                        			Polymorphism, Single Nucleotide
		                        			;
		                        		
		                        			Whole Exome Sequencing
		                        			
		                        		
		                        	
9.Association study between haplotypes of WNT signaling pathway genes and nonsyndromic oral clefts among Chinese Han populations.
Meng Ying WANG ; Wen Yong LI ; Ren ZHOU ; Si Yue WANG ; Dong Jing LIU ; Hong Chen ZHENG ; Zhi Bo ZHOU ; Hong Ping ZHU ; Tao WU ; Yong Hua HU
Journal of Peking University(Health Sciences) 2022;54(3):394-399
		                        		
		                        			OBJECTIVE:
		                        			To explore whether WNT signaling pathway genes were associated with non-syndromic oral clefts (NSOC) based on haplotypes analyses among 1 008 Chinese NSOC case-parent trios.
		                        		
		                        			METHODS:
		                        			The genome-wide association study (GWAS) data of 806 Chinese non-syndromic cleft lip with or without cleft palate (NSCL/P) trios and 202 Chinese non-syndromic cleft palate (NSCP) case-parent trios were drawn from the International Consortium to Identify Genes and Interactions Controlling Oral Clefts (ICOCs) study GWAS data set, whose Chinese study population were recruited from four provinces in China, namely Taiwan, Shandong, Hubei, and Sichuan provinces. The process of DNA genotyping was conducted by the Center for Inherited Disease Research in the Johns Hopkins University, using Illumina Human610-Quad v.1_B Bead Chip. The method of sliding windows was used to determine the haplotypes for analyses, including 2 SNPs haplotypes and 3 SNPs haplotypes. Haplotypes with a frequency lower than 1% were excluded for further analyses. To further assess the association between haplotypes and NSOC risks, and the transmission disequilibrium test (TDT) was performed. The Bonferroni method was adopted to correct multiple tests in the study, with which the threshold of statistical significance level was set as P < 0.05 divided by the number of tests, e.g P < 3.47×10-4 in the current stu-dy. All the statistical analyses were performed by using plink (v1.07).
		                        		
		                        			RESULTS:
		                        			After quality control, a total of 144 single nucleotide polymorphisms (SNPs) mapped in seven genes in WNT signaling pathway were included for the analyses among the 806 Chinese NSCL/P trios and 202 Chinese NSCP trios. A total of 1 042 haplotypes with frequency higher than 1% were included for NSCL/P analyses and another 1 057 haplotypes with frequency higher than 1% were included for NSCP analyses. Results from the TDT analyses showed that a total of 69 haplotypes were nominally associated with the NSCL/P risk among Chinese (P < 0.05). Another 34 haplotypes showed nominal significant association with the NSCP risk among Chinese (P < 0.05). However, none of these haplotypes reached pre-defined statistical significance level after Bonferroni correction (P>3.47×10-4).
		                        		
		                        			CONCLUSION
		                        			This study failed to observe any statistically significant associations between haplotypes of seven WNT signaling pathway genes and the risk of NSOC among Chinese. Further studies are warranted to replicate the findings here.
		                        		
		                        		
		                        		
		                        			Cleft Lip/genetics*
		                        			;
		                        		
		                        			Cleft Palate/genetics*
		                        			;
		                        		
		                        			Genetic Predisposition to Disease
		                        			;
		                        		
		                        			Genome-Wide Association Study
		                        			;
		                        		
		                        			Genotype
		                        			;
		                        		
		                        			Haplotypes
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Polymorphism, Single Nucleotide
		                        			;
		                        		
		                        			Wnt Signaling Pathway/genetics*
		                        			
		                        		
		                        	
10.Impact of prolonging dual antiplatelet therapy on long-term prognosis of elderly patients with coronary heart disease complicated with diabetes mellitus undergoing drug-eluting stent implantation.
Jing Jing XU ; Pei ZHU ; Ying SONG ; De Shan YUAN ; Si Da JIA ; Xue Yan ZHAO ; Yi YAO ; Lin JIANG ; Na XU ; Jian Xin LI ; Yin ZHANG ; Lei SONG ; Li Jian GAO ; Ji Lin CHEN ; Shu Bin QIAO ; Yue Jin YANG ; Bo XU ; Run Lin GAO ; Jin Qing YUAN
Chinese Journal of Cardiology 2022;50(5):450-457
		                        		
		                        			
		                        			Objective: To explore and compare the effect of standard or prolonged dual antiplatelet therapy (DAPT) on the long-term prognosis of elderly patients with coronary heart disease complicated with diabetes mellitus after drug-eluting stent (DES) implantation. Methods: Consecutive patients with diabetes mellitus, ≥65 years old, underwent DES implantation, and had no adverse events within 1 year after operation underwent percutaneous coronary intervention (PCI) from January to December 2013 in Fuwai Hospital were enrolled in this prospective cohort study. These patients were divided into three groups according to DAPT duration: standard DAPT duration group (11 ≤ DAPT duration≤ 13 months) and prolonged DAPT duration group (13
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Coronary Artery Disease/surgery*
		                        			;
		                        		
		                        			Diabetes Mellitus
		                        			;
		                        		
		                        			Drug Therapy, Combination
		                        			;
		                        		
		                        			Drug-Eluting Stents/adverse effects*
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Hemorrhage
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Myocardial Infarction/epidemiology*
		                        			;
		                        		
		                        			Percutaneous Coronary Intervention
		                        			;
		                        		
		                        			Platelet Aggregation Inhibitors/therapeutic use*
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Prospective Studies
		                        			;
		                        		
		                        			Stroke
		                        			;
		                        		
		                        			Treatment Outcome
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail